Biogen Pharmachem [BIOGEN] vs Share India [SHAREINDIA] Detailed Stock Comparison
Biogen Pharmachem
BSE
Loading...
Share India
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Biogen Pharmachem wins in 9 metrics, Share India wins in 9 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Biogen Pharmachem | Share India | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 92.00 | 10.96 | Share India |
| Price-to-Book Ratio | 0.59 | 1.72 | Biogen Pharmachem |
| Debt-to-Equity Ratio | 0.00 | 22.79 | Biogen Pharmachem |
| PEG Ratio | -0.18 | -0.43 | Share India |
| EV/EBITDA | -406.61 | 2.39 | Biogen Pharmachem |
| Profit Margin (TTM) | 74.09% | 24.50% | Biogen Pharmachem |
| Operating Margin (TTM) | 87.17% | 35.76% | Biogen Pharmachem |
| EBITDA Margin (TTM) | 87.17% | 35.76% | Biogen Pharmachem |
| Return on Equity | -0.32% | 13.95% | Share India |
| Return on Assets (TTM) | -0.32% | 8.67% | Share India |
| Free Cash Flow (TTM) | $-10.91M | $-84.97M | Biogen Pharmachem |
| Dividend Yield | N/A | 0.58% | N/A |
| 1-Year Return | -31.06% | -48.15% | Biogen Pharmachem |
| Price-to-Sales Ratio (TTM) | 50.83 | 2.64 | Share India |
| Enterprise Value | $1.19B | $12.85B | Share India |
| EV/Revenue Ratio | 72.85 | 1.02 | Share India |
| Gross Profit Margin (TTM) | N/A | 13.89% | N/A |
| Revenue per Share (TTM) | $0 | $59 | Share India |
| Earnings per Share (Diluted) | $0.01 | $13.89 | Share India |
| Beta (Stock Volatility) | -0.74 | 0.09 | Biogen Pharmachem |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Biogen Pharmachem vs Share India Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Biogen Pharmachem | -1.09% | 3.41% | -2.15% | -10.78% | -11.65% | -22.88% |
| Share India | -3.10% | -4.82% | -12.67% | -10.99% | -27.67% | -49.22% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Biogen Pharmachem | -31.06% | -3.19% | 127.50% | 127.50% | 127.50% | 127.50% |
| Share India | -48.15% | -33.45% | 633.03% | 633.03% | 633.03% | 633.03% |
Performance & Financial Health Analysis: Biogen Pharmachem vs Share India
| Metric | BIOGEN | SHAREINDIA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹830.39M | ₹33.23B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 653,936 | 378,321 |
| 90 Day Avg. Volume | 1,012,415 | 374,719 |
| Last Close | ₹0.91 | ₹152.25 |
| 52 Week Range | ₹0.75 - ₹1.45 | ₹141.21 - ₹344.80 |
| % from 52W High | -37.24% | -55.84% |
| All-Time High | ₹1.85 (Mar 14, 2022) | ₹405.28 (Feb 19, 2024) |
| % from All-Time High | -50.81% | -62.43% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | -0.21% |
| Quarterly Earnings Growth | -1.00% | -0.18% |
| Financial Health | ||
| Profit Margin (TTM) | 0.74% | 0.25% |
| Operating Margin (TTM) | 0.87% | 0.36% |
| Return on Equity (TTM) | 0.00% | 0.14% |
| Debt to Equity (MRQ) | 0.00 | 22.79 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹1.56 | ₹88.31 |
| Cash per Share (MRQ) | ₹0.02 | ₹123.45 |
| Operating Cash Flow (TTM) | ₹-10,911,000 | ₹628.12M |
| Levered Free Cash Flow (TTM) | ₹-2,927,000 | ₹3.28B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.58% |
| Last 12-Month Dividend | N/A | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Biogen Pharmachem vs Share India
| Metric | BIOGEN | SHAREINDIA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 92.00 | 10.96 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -0.18 | -0.43 |
| Price to Sales (TTM) | 50.83 | 2.64 |
| Price to Book (MRQ) | 0.59 | 1.72 |
| Market Capitalization | ||
| Market Capitalization | ₹830.39M | ₹33.23B |
| Enterprise Value | ₹1.19B | ₹12.85B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 72.85 | 1.02 |
| Enterprise to EBITDA | -406.61 | 2.39 |
| Risk & Other Metrics | ||
| Beta | -0.74 | 0.09 |
| Book Value per Share (MRQ) | ₹1.56 | ₹88.31 |
Financial Statements Comparison: Biogen Pharmachem vs Share India
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BIOGEN | SHAREINDIA |
|---|---|---|
| Revenue/Sales | ₹0 | ₹1.13B |
| Cost of Goods Sold | ₹633,000 | ₹894.20M |
| Gross Profit | ₹-633,000 | ₹239.35M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹13.45M | ₹464.48M |
| EBITDA | ₹13.45M | ₹555.43M |
| Pre-Tax Income | ₹13.45M | ₹230.95M |
| Income Tax | ₹0 | ₹44.49M |
| Net Income (Profit) | ₹13.45M | ₹186.46M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BIOGEN | SHAREINDIA |
|---|---|---|
| Cash & Equivalents | ₹548,000 | ₹5.45B |
| Total Current Assets | ₹26.56M | ₹32.11B |
| Total Current Liabilities | ₹900,000 | ₹4.15B |
| Long-Term Debt | ₹0 | ₹5.13B |
| Total Shareholders Equity | ₹919.28M | ₹23.49B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | N/A | ₹664.24M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BIOGEN | SHAREINDIA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BIOGEN | SHAREINDIA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 653,936 | 378,321 |
| Average Daily Volume (90 Day) | 1,012,415 | 374,719 |
| Shares Outstanding | 652.60M | 218.22M |
| Float Shares | 1.10B | 78.74M |
| % Held by Insiders | 0.41% | 0.63% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Biogen Pharmachem vs Share India
| Metric | BIOGEN | SHAREINDIA |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹1.00 |
| Last 12-Month Dividend Yield | N/A | 0.58% |
| 3-Year Avg Annual Dividend | N/A | ₹0.73 |
| 3-Year Avg Dividend Yield | N/A | 0.11% |
| 3-Year Total Dividends | N/A | ₹2.18 |
| Ex-Dividend Date | N/A | Aug 05, 2025 |